An important player in the global fight against AIDS, India has called for expanding antiretroviral therapy coverage to combat HIV/AIDS. Emphasising the importance of continued political commitment, a senior diplomat has said competing financing demands and changing priorities should not affect efforts to provide adequate resources to fight HIV/AIDS, reports The Pharma Letter’s India correspondent.
Taking a lead in the global fight against AIDS, India is supplying the world with two-thirds of the drugs to treat those infected with HIV, according to Indian diplomat Paulomi Tripathi.
Speaking at the UN General Assembly, Ms Tripathi, a First Secretary in India's UN mission said these affordable generic medicines have helped scale up access to treatment across developing countries, as almost two-thirds of the antiretroviral drugs used globally are supplied by the Indian pharmaceutical industry.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze